Lantheus Holdings (LNTH) Gross Margin (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Gross Margin came in at 61.2% in Q1 2026, down 257.0% year-on-year from 38.98% in Q1 2025, and up 3.35% on a QoQ basis from 59.21% in Q4 2025.
Lantheus Holdings (LNTH) Gross Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Gross Margin data on file, last reported at 61.2% in Q1 2026.
- On a quarterly basis, Gross Margin fell 257.0% year-over-year to 61.2% in Q1 2026; TTM through Mar 2026 was 60.48%, a 356.0% decrease from a year earlier, with the FY2025 full-year figure at 61.1%, down 333.0% from the prior year.
- Gross Margin for Q1 2026 stood at 61.2%, up from 59.21% in the prior quarter.
- Over the last five years, Gross Margin for LNTH reached as high as 1532.46% in Q4 2023 and fell as low as 25.63% in Q1 2023.
- Historically, Gross Margin has averaged 146.81% across 5 years, with a median of 62.99% in 2023.
- Across the five-year window, Gross Margin jumped 146894 bps in 2023 and slumped 146891 bps in 2024, its largest moves.
- Year by year, Gross Margin stood at 63.52% in 2022, then jumped by 2312 bps to 1532.46% in 2023, then slumped by 96 bps to 63.55% in 2024, then decreased by 7 bps to 59.21% in 2025, then climbed by 3 bps to 61.2% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 61.2% in Q1 2026, 59.21% in Q4 2025, and 57.91% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 61.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.20% |
| Dec 31, 2025 | 59.21% |
| Sep 30, 2025 | 57.91% |
| Jun 30, 2025 | 63.75% |
| Mar 31, 2025 | 63.77% |
| Dec 31, 2024 | 63.55% |
| Sep 30, 2024 | 63.93% |
| Jun 30, 2024 | 64.90% |
| Mar 31, 2024 | 65.37% |
| Dec 31, 2023 | 1,532.46% |
| Sep 30, 2023 | 62.50% |
| Jun 30, 2023 | 62.99% |
| Mar 31, 2023 | 25.63% |
| Dec 31, 2022 | 63.52% |
| Sep 30, 2022 | 61.61% |
| Jun 30, 2022 | 61.70% |
| Mar 31, 2022 | 61.79% |
| Dec 31, 2021 | 44.70% |
| Sep 30, 2021 | 41.80% |
| Jun 30, 2021 | 45.60% |